Research programme: viral and bacterial infections therapeutics - Starpharma

Drug Profile

Research programme: viral and bacterial infections therapeutics - Starpharma

Alternative Names: Angiogenesis inhibitor research programme - Starpharma Pooled Developments; Second-generation dendrimers research programme - Starpharma Pooled Developments; Topical microbicides research programme - Starpharma Pooled Developments

Latest Information Update: 29 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Biomolecular Research Institute
  • Developer Starpharma
  • Class Dendrimers
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections; Hepatitis B; Respiratory tract infections; Sexually transmitted infections; Viral infections

Most Recent Events

  • 06 Oct 2006 Preclinical trials in Hepatitis B in Australia (unspecified route)
  • 06 Oct 2006 Preclinical trials in Respiratory tract infections in Australia (unspecified route)
  • 31 May 2004 Preclinical trials in Venereal infections in Australia (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top